Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

HUM · Humana Inc.

$417.22 -1.15% Oct 26 close
Detected setup Partial Move · Setup Score 68/100

Stand aside — setup invalidated

Setup score 68, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about HUM

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$HUM

Humana Inc.

Humana Inc. is a large-cap Managed Health Care company in the Health Services sector with a market cap of $52B.

Health Services Managed Health Care stock Stage 2 · Advancing Base 1
$417.22 latest close
Market Structure
Trend structure: range
Latest event: structure_shift (bearish)
Join to Watchlist $HUM Share card
Verdict · setup score 68/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 68, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Recent price action · daily
$400$450AugSepOct$417

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 2. Quarterly EPS growth ≥ 25% — -26.2% QoQ
  • Minervini 2. ROE ≥ 17% — ROE 6.9%
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -26.2% QoQ
  • O'Neil A: Annual earnings & revenue quality — Rev -1.2% | ROE 6.9%
  • Weinstein Volume expansion above average — Volume ratio 1.01x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 9/13 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
70 Strong
Legend Score · rates the stock Strong (70/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 95
  • Trend Template (25%) 100
  • Institutional Footprint (20%) 51
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 94: top 6% of all stocks — true leadership. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 51: neutral — no clear institutional conviction. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Normal technical setup

Next earnings Friday, November 6, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

HUM-1.15%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. HUM was -1.15 points vs XLV. -1.86 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.15% From the open-2.12% Range position13% GapNo gap
QQQ confirmationDiverging (+1.11%) SMH confirmationDiverging (+2.74%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $417.22 -1.1% Oct 26 close
52W High $456.50 8.6% below high
Wks Since High 2w
Base Depth 10.7%
RS Rank 87 percentile of scan
SMA 50 $398.35
Avg Vol 1,287,977
Rel Vol (Oct 26) 1.01× 0.48× on up days
More stats
52W Low $163.11
Tight Wks 0
Base B1
SMA 200 $305.55
RS Line vs High -2.7%
RS Line Slope +7.7% ▲
Group Rank #23/66
ADR% 3.7%
ATR(14) $19.58 (4.7%)
Vol Pace (live) N/A
A/D Days 16A / 14D
A/D Rating B
VDU Bars 0/10 d
Power Trend 12d
Earnings in 10d
Position in 52-week range 87thpercentile of the 52-week range
$163.11low
$456.50high

HUM Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for HUM.

Create Free Account

Technical Analysis Report Card

$HUM · $417.22 · as of 2026-10-26 · multi-factor read
78
/ 100
Technicals 78/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$398.35 ↑
100-day$389.60 ↑
200-day$305.55 ↑
Bullish (50 > 200)

RSI (14)

Reading54.0 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.108

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width59% · 17.8%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.48 · Distribution
Rel volume1.01×
Pocket pivots · 10d0
5d vs 50d vol127%
Heavy vol up / down3 / 4

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is expanding versus its baseline.

  • 4 heavy-volume down days vs 3 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $419.97swing level
R · $428.88swing level
R · $456.5052-week high
Price · $417.22now
S · $407.50swing level
S · $385.22swing level
S · $375.86swing level

Fibonacci · Uptrend swing

23.6%$405.32
38.2%$373.66
50.0%$348.07
61.8%$322.49
78.6%$286.06

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for HUM — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume distribution
Want this read in a legend's voice? Ask a Legend about HUM
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (68/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Watch C Trend-template read: 9/13 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $417.22, MA150 $340.07, MA200 $305.55
1.2 150-day MA > 200-day MAMA150 $340.07 vs MA200 $305.55
Failing evidence
2. Quarterly EPS growth ≥ 25%-26.2% QoQ
2. ROE ≥ 17%ROE 6.9%
9/13 checks
Method → Playbook → Ask →
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (2/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 94
N: Near 52-week high or RS line new high8.6% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-26.2% QoQ
A: Annual earnings & revenue qualityRev -1.2% | ROE 6.9%
2/8 checks
Method → Playbook → Ask →
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $417.22 vs MA200 $305.55
Failing evidence
Volume expansion above averageVolume ratio 1.01x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
dennis Watch C Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $375.86
Volatility-unit sizing (1N ≈ 1% of equity)1N = $16.05 (3.85% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/8 checks
Method → Playbook → Ask →
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $479.80-$500.66; trail the rest
Failing evidence
Named Zanger pattern onlyPartial Move is not one of Zanger's six
Breakout volume 1.5-2.0x averageNot confirmed
4/6 checks
Method → Playbook → Ask →
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Reasonable price for the growth (P/E ≤ 35); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Price strength (RS ≥ 70)RS score 94 — Zweig buys strength, not bargains
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (1995 adv / 1699 dec) — participation expanding
Failing evidence
EPS growth above the market (≥15% QoQ)-26.2% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 40.5x — no PEG or forward P/E stored
3/8 checks
Method → Playbook → Ask →
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$417.22
Relative strengthRS 94
Failing evidence
Volume vs average1.01x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

partialConsolidating within the box (8.6% from 52W high) — patience until it approaches the prior high.

Passing evidence
Price$417.22
Relative strengthRS 94
Failing evidence
Volume vs average1.01x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$417.22
Relative strengthRS 94
Failing evidence
Volume vs average1.01x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bearish Engulfing — Today's down candle engulfs yesterday's up candle — a bearish reversal warning, most significant after an extended advance.

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
128RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -2 B
A: 14 D: 16 Net: -265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -26%
✗ Revenue growth ≥20% YoY -1%
✗ Gross margin ≥30% —
✗ ROE ≥17% 7%
✓ RS rating ≥80 (leadership) 94
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -8.6%

Method Playbook

Trade it like Zanger EXACT LEVELS · PRO
Zanger C · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the breakout point of a named pattern (flat base, bull flag, ascending triangle, cup and handle, double bottom, symmetrical triangle).
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Buy the breakout day on 150-200% of average volume. Never pay more than 5% above the breakout point.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Set the stop 2-3% below entry and sell on bad price action before it is even hit.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Sell 20-30% of the position at +15-20% from the breakout, then trail the rest on the 10/20-day moving average.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Out on a break of the 10/20-day MA, a failed breakout back below the pivot, or a reversal pattern — winners are held, laggards are sold fast.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish near confirmation
90% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~412.67 (neckline) to confirm, with measured-move risk toward ~368.85. A push back above 434.12 weakens the pattern; reclaiming 456.50 invalidates it.

Confirms below 412.67
Invalidates at 456.50
Left Shoulder 428.88
Head 456.50
Right Shoulder 434.12
Neckline 412.67
Target 368.85

LS 428.88 / head 456.50 / RS 434.12, neckline ~412.67, vol_fading=yes

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Partial Move ⚠ Head & shoulders top forming
68 setup score
RS Score 94
Trend template 8/8 ✓
CANSLIM 65.6* (B)
predictor: ✓ predicted direction: up probability: 0.72 retrace pct: 47.7 formation low: 353.69 formation high: 456.5 volume ratio: 1.228 depth pct: 22.52 validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 8/8 confirmed
Why This Setup? D+W Confluence
Partial Move · schematic

Partial decline stalled at 47.7% of range (353.69–456.50) without touching the bottom; predicts upward break ~72% of the time. Predictor — breakout not confirmed. | Strong trend (8/8) | Top RS (94) | High-confidence pattern (72%) | Power Trend | Stage 2 | Readiness 65/100 (watch) | CANSLIM 65.6 (B) | ⚠ Head & shoulders top forming

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

5/7 universals met
  • Clear of earnings — partly met in 10 days — size down
  • Volume confirms — partly met 1.0× average — light
  • A relative-strength leader — met RS rank 87
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
  • Not chasing (in range) — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $417.22 vs SMA150 $340.07 / SMA200 $305.55
SMA 150 above SMA 200 SMA150 $340.07 vs SMA200 $305.55
SMA 200 trending up Slope +14.65 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $398.35
Price above SMA 50 $417.22 vs SMA50 $398.35
30%+ above 52-week low +155.8% from $163.11
Within 25% of 52-week high -8.6% from $456.50
RS score above 70 RS 94

Fundamentals

52W Range
87%
Mkt Cap SEC
51.9B
EPS QoQ
-26%
Rev YoY
-1%
ROE
7%
D/E
0.70
EPS TTM
$10.56
P/E TTM
39.5x
Float
120M
Insider
No Buy

Company

Company profile
Humana Inc.
HUM · NYSE · Health Services · Managed Health Care
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 65.6* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
59
N · New Highs
100
S · Supply/Demand
45
L · Leader RS
94
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$213.90
W. Resist
$456.50
W. Patterns
Record Volume
Weekly Structure

Scan History

20× streak
Oct 23: 68 (Wyckoff SOS)Oct 26: 68 (Wyckoff SOS)Oct 27: 68 (Partial Move)68
Oct 27
Partial Move ✓ Gate
68
Oct 26
Wyckoff SOS ✓ Gate
68 0.0%
Oct 23
Wyckoff SOS ✓ Gate
68 -1.1%

Latest News

Headlines for HUM
Loading headlines…

Get the full picture on HUM

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial